Literature DB >> 20420766

Medial prefrontal cortex activity during memory encoding of pictures and its relation to symptomatic improvement after citalopram treatment in patients with major depression.

Martin Roy1, Philippe-Olivier Harvey, Marcelo T Berlim, Firoza Mamdani, Marie-Martine Beaulieu, Gustavo Turecki, Martin Lepage.   

Abstract

BACKGROUND: Brain imaging studies of major depressive disorder have shown alterations in the brain regions typically involved in episodic memory, including the prefrontal cortex and medial temporal areas. Some studies of major depressive disorder have linked episodic memory performance to treatment response. In this study, we sought to identify brain regions whose activity, measured during the encoding of pictures, predicted symptomatic improvement after 8 weeks of citalopram treatment.
METHODS: We included 20 unmedicated depressed patients. These patients performed an episodic recognition memory task during functional magnetic resonance imaging. During the encoding phase, 150 pictures depicting emotionally positive, negative or neutral content were presented, and the participants were required to classify each picture according to its emotional valence. The same 150 pictures were presented, along with 150 new ones, for a recognition task. We asked participants to distinguish the old pictures from the new ones. We assessed symptom severity by use of the 21-item Hamilton Rating Scale for Depression (HAM-D) at baseline and after 8 weeks of citalopram treatment. We performed subsequent memory effect analyses using SPM2 software. We explored the relation between brain activation during successful encoding of pictures and symptomatic improvement.
RESULTS: Patients showed a mean symptomatic improvement of 54.5% on the HAM-D after 8 weeks. Symptomatic improvement was significantly and positively correlated with picture recognition memory accuracy. We also found that the activity of the ventromedial prefrontal cortex and anterior cingulate cortex during successful encoding was significantly correlated with symptomatic improvement. Finally, we found greater activation in the ventromedial prefrontal cortex during the successful encoding of positive pictures in comparison with neutral pictures. LIMITATIONS: During the recognition memory task, 5 participants (among the best responders to treatment) were not included in the valence-specific analyses because they had very few errors. A more challenging task would have allowed the inclusion of most patients.
CONCLUSION: Different types of functional imaging paradigms have been used to explore whether the activity of specific brain regions measured at baseline is predictive of a better response to treatment in major depressive disorder. Among these regions, the medial prefrontal cortex and anterior cingulate cortex usually show the strongest predictive value. According to our results, the medial prefrontal cortex and anterior cingulate cortex could have an effect on treatment response in major depressive disorder by contributing to the successful encoding of positively valenced information.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20420766      PMCID: PMC2861132     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  46 in total

Review 1.  Neurobiology of emotion perception I: The neural basis of normal emotion perception.

Authors:  Mary L Phillips; Wayne C Drevets; Scott L Rauch; Richard Lane
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

Review 2.  Depression: perspectives from affective neuroscience.

Authors:  Richard J Davidson; Diego Pizzagalli; Jack B Nitschke; Katherine Putnam
Journal:  Annu Rev Psychol       Date:  2002       Impact factor: 24.137

3.  Does processing of emotional stimuli predict symptomatic improvement and diagnostic recovery from major depression?

Authors:  Sheri L Johnson; Jutta Joormann; Ian H Gotlib
Journal:  Emotion       Date:  2007-02

4.  Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.

Authors:  Sanjaya Saxena; Arthur L Brody; Matthew L Ho; Narineh Zohrabi; Karron M Maidment; Lewis R Baxter
Journal:  Am J Psychiatry       Date:  2003-03       Impact factor: 18.112

5.  Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression.

Authors:  John T Little; Terence A Ketter; Tim A Kimbrell; Robert T Dunn; Brenda E Benson; Mark W Willis; David A Luckenbaugh; Robert M Post
Journal:  Biol Psychiatry       Date:  2005-02-01       Impact factor: 13.382

Review 6.  Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview.

Authors:  Marcelo T Berlim; Marcelo P Fleck; Gustavo Turecki
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

7.  Lower hippocampal volume in patients suffering from depression: a meta-analysis.

Authors:  Stephanie Campbell; Michael Marriott; Claude Nahmias; Glenda M MacQueen
Journal:  Am J Psychiatry       Date:  2004-04       Impact factor: 18.112

8.  Activation of the human orbitofrontal cortex to a liquid food stimulus is correlated with its subjective pleasantness.

Authors:  M L Kringelbach; J O'Doherty; E T Rolls; C Andrews
Journal:  Cereb Cortex       Date:  2003-10       Impact factor: 5.357

9.  Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression.

Authors:  Darin D Dougherty; Anthony P Weiss; G Rees Cosgrove; Nathaniel M Alpert; Edwin H Cassem; Andrew A Nierenberg; Bruce H Price; Helen S Mayberg; Alan J Fischman; Scott L Rauch
Journal:  J Neurosurg       Date:  2003-12       Impact factor: 5.115

Review 10.  Applications of fMRI in translational medicine and clinical practice.

Authors:  Paul M Matthews; Garry D Honey; Edward T Bullmore
Journal:  Nat Rev Neurosci       Date:  2006-09       Impact factor: 34.870

View more
  12 in total

Review 1.  Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.

Authors:  Mary L Phillips; Henry W Chase; Yvette I Sheline; Amit Etkin; Jorge R C Almeida; Thilo Deckersbach; Madhukar H Trivedi
Journal:  Am J Psychiatry       Date:  2015-02-01       Impact factor: 18.112

Review 2.  Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years.

Authors:  G Voegeli; M L Cléry-Melin; N Ramoz; P Gorwood
Journal:  Drugs       Date:  2017-12       Impact factor: 9.546

3.  Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse.

Authors:  Yuen-Siang Ang; Roselinde Kaiser; Thilo Deckersbach; Jorge Almeida; Mary L Phillips; Henry W Chase; Christian A Webb; Ramin Parsey; Maurizio Fava; Patrick McGrath; Myrna Weissman; Phil Adams; Patricia Deldin; Maria A Oquendo; Melvin G McInnis; Thomas Carmody; Gerard Bruder; Crystal M Cooper; Cherise R Chin Fatt; Madhukar H Trivedi; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2020-04-23       Impact factor: 13.382

4.  Pretreatment anterior cingulate activity predicts antidepressant treatment response in major depressive episodes.

Authors:  Johannes Rentzsch; Mazda Adli; Katja Wiethoff; Ana Gómez-Carrillo de Castro; Jürgen Gallinat
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-20       Impact factor: 5.270

5.  Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics.

Authors:  Greg J Siegle; Wesley K Thompson; Amanda Collier; Susan R Berman; Joshua Feldmiller; Michael E Thase; Edward S Friedman
Journal:  Arch Gen Psychiatry       Date:  2012-09

Review 6.  Promises and challenges of human computational ethology.

Authors:  Dean Mobbs; Toby Wise; Nanthia Suthana; Noah Guzmán; Nikolaus Kriegeskorte; Joel Z Leibo
Journal:  Neuron       Date:  2021-06-17       Impact factor: 18.688

7.  Healthy individuals treated with clomipramine: an fMRI study of brain activity during autobiographical recall of emotions.

Authors:  C T Cerqueira; J R Sato; J R C de Almeida; E Amaro; C C Leite; C Gorenstein; V Gentil; G F Busatto
Journal:  Transl Psychiatry       Date:  2014-07-01       Impact factor: 6.222

Review 8.  Diagnostic and therapeutic utility of neuroimaging in depression: an overview.

Authors:  Toby Wise; Anthony J Cleare; Andrés Herane; Allan H Young; Danilo Arnone
Journal:  Neuropsychiatr Dis Treat       Date:  2014-08-19       Impact factor: 2.570

9.  Default mode network deactivation during emotion processing predicts early antidepressant response.

Authors:  M Spies; C Kraus; N Geissberger; B Auer; M Klöbl; M Tik; I-L Stürkat; A Hahn; M Woletz; D M Pfabigan; S Kasper; C Lamm; C Windischberger; R Lanzenberger
Journal:  Transl Psychiatry       Date:  2017-01-24       Impact factor: 6.222

10.  Functional MRI of emotional memory in adolescent depression.

Authors:  Rosemary J Holt; Julia M Graham; Kirstie J Whitaker; Cindy C Hagan; Cinly Ooi; Paul O Wilkinson; Adrienne O van Nieuwenhuizen; Belinda R Lennox; Barbara J Sahakian; Ian M Goodyer; Edward T Bullmore; John Suckling
Journal:  Dev Cogn Neurosci       Date:  2015-12-31       Impact factor: 6.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.